A recent systematic review shows evidence that sFlt-1, PlGF, IL-6, IL-6/IL-10 ratios are interesting candidate biomarkers for cardiovascular risk stratification after PE or HELLP syndrome (hemolysis, elevated liver enzymes and low platelets) [14]. This evidence concerns the gene IL10 and HELLP syndrome.